BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23311322)

  • 41. The Wnt/β-catenin/T-cell factor 4 pathway up-regulates high-mobility group A1 expression in colon cancer.
    Bush BM; Brock AT; Deng JA; Nelson RA; Sumter TF
    Cell Biochem Funct; 2013 Apr; 31(3):228-36. PubMed ID: 22961697
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thyroid cell transformation requires the expression of the HMGA1 proteins.
    Berlingieri MT; Pierantoni GM; Giancotti V; Santoro M; Fusco A
    Oncogene; 2002 May; 21(19):2971-80. PubMed ID: 12082527
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HMGA1-pseudogene7 transgenic mice develop B cell lymphomas.
    De Martino M; De Biase D; Forzati F; Credendino SC; Palma G; Barbieri A; Arra C; Paciello O; Gaudio E; Ponzoni M; De Vita G; Chieffi P; Bertoni F; Fusco A; Esposito F
    Sci Rep; 2020 Apr; 10(1):7057. PubMed ID: 32341372
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Double knock-out of Hmga1 and Hipk2 genes causes perinatal death associated to respiratory distress and thyroid abnormalities in mice.
    Gerlini R; Amendola E; Conte A; Valente V; Tornincasa M; Credendino SC; Cammarota F; Gentile C; Di Guida L; Paladino S; De Vita G; Fusco A; Pierantoni GM
    Cell Death Dis; 2019 Oct; 10(10):747. PubMed ID: 31582725
    [TBL] [Abstract][Full Text] [Related]  

  • 45. "Best friends" sharing the HMGA1 gene: comparison of the human and canine HMGA1 to orthologous other species.
    Murua Escobar H; Soller JT; Richter A; Meyer B; Winkler S; Bullerdiek J; Nolte I
    J Hered; 2005; 96(7):777-81. PubMed ID: 15958792
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genomic characterisation, chromosomal assignment and in vivo localisation of the canine high mobility group A1 (HMGA1) gene.
    Beuing C; Soller JT; Muth M; Wagner S; Dolf G; Schelling C; Richter A; Willenbrock S; Reimann-Berg N; Winkler S; Nolte I; Bullerdiek J; Murua Escobar H
    BMC Genet; 2008 Jul; 9():49. PubMed ID: 18651940
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapy of human pancreatic carcinoma based on suppression of HMGA1 protein synthesis in preclinical models.
    Trapasso F; Sarti M; Cesari R; Yendamuri S; Dumon KR; Aqeilan RI; Pentimalli F; Infante L; Alder H; Abe N; Watanabe T; Viglietto G; Croce CM; Fusco A
    Cancer Gene Ther; 2004 Sep; 11(9):633-41. PubMed ID: 15272314
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human KIT ligand promoter is positively regulated by HMGA1 in breast and ovarian cancer cells.
    Treff NR; Dement GA; Adair JE; Britt RL; Nie R; Shima JE; Taylor WE; Reeves R
    Oncogene; 2004 Nov; 23(52):8557-62. PubMed ID: 15378028
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High-mobility group A1 proteins enhance the expression of the oncogenic miR-222 in lung cancer cells.
    Zhang Y; Ma T; Yang S; Xia M; Xu J; An H; Yang Y; Li S
    Mol Cell Biochem; 2011 Nov; 357(1-2):363-71. PubMed ID: 21656127
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cdkn2a is an atherosclerosis modifier locus that regulates monocyte/macrophage proliferation.
    Kuo CL; Murphy AJ; Sayers S; Li R; Yvan-Charvet L; Davis JZ; Krishnamurthy J; Liu Y; Puig O; Sharpless NE; Tall AR; Welch CL
    Arterioscler Thromb Vasc Biol; 2011 Nov; 31(11):2483-92. PubMed ID: 21868699
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human papilloma virus-dependent HMGA1 expression is a relevant step in cervical carcinogenesis.
    Mellone M; Rinaldi C; Massimi I; Petroni M; Veschi V; Talora C; Truffa S; Stabile H; Frati L; Screpanti I; Gulino A; Giannini G
    Neoplasia; 2008 Aug; 10(8):773-81. PubMed ID: 18670638
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HAND1 gene expression is negatively regulated by the High Mobility Group A1 proteins and is drastically reduced in human thyroid carcinomas.
    Martinez Hoyos J; Ferraro A; Sacchetti S; Keller S; De Martino I; Borbone E; Pallante P; Fedele M; Montanaro D; Esposito F; Cserjesi P; Chiariotti L; Troncone G; Fusco A
    Oncogene; 2009 Feb; 28(6):876-85. PubMed ID: 19060921
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HMGA1 is a determinant of cellular invasiveness and in vivo metastatic potential in pancreatic adenocarcinoma.
    Liau SS; Jazag A; Whang EE
    Cancer Res; 2006 Dec; 66(24):11613-22. PubMed ID: 17178855
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Loss of Smad3 in acute T-cell lymphoblastic leukemia.
    Wolfraim LA; Fernandez TM; Mamura M; Fuller WL; Kumar R; Cole DE; Byfield S; Felici A; Flanders KC; Walz TM; Roberts AB; Aplan PD; Balis FM; Letterio JJ
    N Engl J Med; 2004 Aug; 351(6):552-9. PubMed ID: 15295048
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HMGA1 and MMP-11 Are Overexpressed in Human Non-melanoma Skin Cancer.
    Greco M; Arcidiacono B; Chiefari E; Vitagliano T; Ciriaco AG; Brunetti FS; Cuda G; Brunetti A
    Anticancer Res; 2018 Feb; 38(2):771-778. PubMed ID: 29374701
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hhex induces promyelocyte self-renewal and cooperates with growth factor independence to cause myeloid leukemia in mice.
    Jackson JT; Ng AP; Shields BJ; Haupt S; Haupt Y; McCormack MP
    Blood Adv; 2018 Feb; 2(4):347-360. PubMed ID: 29453249
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CDKN2A/B alterations impair prognosis in adult BCR-ABL1-positive acute lymphoblastic leukemia patients.
    Iacobucci I; Ferrari A; Lonetti A; Papayannidis C; Paoloni F; Trino S; Storlazzi CT; Ottaviani E; Cattina F; Impera L; Abbenante MC; Vignetti M; Vitale A; Potenza L; Paolini S; Soverini S; Pane F; Luppi M; Foà R; Baccarani M; Martinelli G
    Clin Cancer Res; 2011 Dec; 17(23):7413-23. PubMed ID: 22134481
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Constitutive Kit activity triggers B-cell acute lymphoblastic leukemia-like disease in mice.
    Weidemann RR; Behrendt R; Schoedel KB; Müller W; Roers A; Gerbaulet A
    Exp Hematol; 2017 Jan; 45():45-55.e6. PubMed ID: 27664314
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Deletion of CDKN2A/B is associated with inferior relapse free survival in pediatric B cell acute lymphoblastic leukemia.
    Kathiravan M; Singh M; Bhatia P; Trehan A; Varma N; Sachdeva MS; Bansal D; Jain R; Naseem S
    Leuk Lymphoma; 2019 Feb; 60(2):433-441. PubMed ID: 29966470
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inactivation of the Dlc1 gene cooperates with downregulation of p15INK4b and p16Ink4a, leading to neoplastic transformation and poor prognosis in human cancer.
    Qian X; Durkin ME; Wang D; Tripathi BK; Olson L; Yang XY; Vass WC; Popescu NC; Lowy DR
    Cancer Res; 2012 Nov; 72(22):5900-11. PubMed ID: 23010077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.